primary hyperaldosteronism
Information
- Disease name
- primary hyperaldosteronism
- Disease ID
- DOID:446
- Description
- "An adrenal gland hyperfunction disease that results in the overproduction of aldosterone by the adrenal glands." [url:https\://en.wikipedia.org/wiki/Primary_aldosteronism, url:https\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=16.12d&ns=NCI_Thesaurus&code=C34510]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00732771 | Completed | Phase 2 | Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism | June 2008 | |
| NCT01567111 | Completed | N/A | 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism | February 2012 | March 2019 |
| NCT01728493 | Completed | Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment | September 2013 | February 2016 | |
| NCT01761344 | Completed | N/A | Intraoperative Analysis of Cortisol During Adrenal Vein Sampling | January 2013 | August 2013 |
| NCT01978132 | Completed | N/A | Primary Hyperaldosteronism and Ischemia-reperfusion Injury | November 2013 | July 1, 2017 |
| NCT02934399 | Completed | Dynamic Hormone Diagnostics in Endocrine Disease | October 2016 | November 14, 2023 | |
| NCT02938910 | Completed | Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism | November 2012 | October 2014 | |
| NCT03405025 | Completed | N/A | Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas | February 21, 2018 | May 10, 2023 |
| NCT03474237 | Enrolling by invitation | A Prospective Cohort Study for Patients With Adrenal Diseases | October 1, 2018 | December 31, 2027 | |
| NCT04251780 | Recruiting | N/A | Tissue K+ in Primary Hyperaldosteronism | January 1, 2018 | December 31, 2023 |
| NCT04278404 | Recruiting | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | March 5, 2020 | July 2024 | |
| NCT05636995 | Recruiting | HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial) | January 10, 2023 | December 2024 |
- Disase is a (Disease Ontology)
- DOID:3947
- Cross Reference ID (Disease Ontology)
- ICD10CM:E24
- Cross Reference ID (Disease Ontology)
- ICD10CM:E26
- Cross Reference ID (Disease Ontology)
- ICD9CM:255.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:255.1
- Cross Reference ID (Disease Ontology)
- MESH:D003480
- Cross Reference ID (Disease Ontology)
- MESH:D006929
- Cross Reference ID (Disease Ontology)
- MIM:605635
- Cross Reference ID (Disease Ontology)
- MIM:613677
- Cross Reference ID (Disease Ontology)
- NCI:C113213
- Cross Reference ID (Disease Ontology)
- NCI:C2969
- Cross Reference ID (Disease Ontology)
- ORDO:235936
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:154705004
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:88213004
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0010481
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0020428
- Exact Synonym (Disease Ontology)
- Cushing syndrome
- Exact Synonym (Disease Ontology)
- Cushing's syndrome
- Exact Synonym (Disease Ontology)
- hyperaldosteronism
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0011736
- ICD10 preferred id (Insert disease from ICD10)
- D0003714
- ICD10 class code (Insert disease from ICD10)
- E26.0